lyme disease

Showing 2 posts of 2 posts found.

Valneva and Pfizer share positive results from phase 2 trial for Lyme disease vaccine candidate

September 7, 2023
Medical Communications Infections and infestations, Pfizer, Vaccine, Valneva, clinical trial, lyme disease

Valneva and Pfizer have announced positive paediatric and adolescent immunogenicity and safety data for their Lyme disease vaccine candidate, VLA15, …


FDA fast tracks Valneva’s Lyme disease vaccine

August 7, 2017
Research and Development, Sales and Marketing Valneva, biotech, life sciences, lyme disease, medicines, pharma, pharmaceutcial

French firm Valneva has announced that its Lyme disease vaccine, known at this stage only by VLA15, has been fast-tracked …

Latest content